Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial
Radiotherapy is the standard salvage treatment after radical prostatectomy. To date, the role of androgen deprivation therapy has not been formally shown. In this follow-up study, we aimed to update the results of the GETUG-AFU 16 trial, which assessed the efficacy of radiotherapy plus androgen supp...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Carrie, Christian [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2019 |
|---|
| Umfang: |
10 |
|---|
| Übergeordnetes Werk: |
Enthalten in: My - Citovsky, Vitaly ELSEVIER, 2019, London |
|---|---|
| Übergeordnetes Werk: |
volume:20 ; year:2019 ; number:12 ; pages:1740-1749 ; extent:10 |
| Links: |
|---|
| DOI / URN: |
10.1016/S1470-2045(19)30486-3 |
|---|
| Katalog-ID: |
ELV048678724 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV048678724 | ||
| 003 | DE-627 | ||
| 005 | 20230624145646.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200108s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S1470-2045(19)30486-3 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001094.pica |
| 035 | |a (DE-627)ELV048678724 | ||
| 035 | |a (ELSEVIER)S1470-2045(19)30486-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 570 |q VZ |
| 084 | |a BIODIV |q DE-30 |2 fid | ||
| 084 | |a 35.70 |2 bkl | ||
| 084 | |a 42.12 |2 bkl | ||
| 100 | 1 | |a Carrie, Christian |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial |
| 264 | 1 | |c 2019 | |
| 300 | |a 10 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Radiotherapy is the standard salvage treatment after radical prostatectomy. To date, the role of androgen deprivation therapy has not been formally shown. In this follow-up study, we aimed to update the results of the GETUG-AFU 16 trial, which assessed the efficacy of radiotherapy plus androgen suppression versus radiotherapy alone. | ||
| 700 | 1 | |a Magné, Nicolas |4 oth | |
| 700 | 1 | |a Burban-Provost, Patricia |4 oth | |
| 700 | 1 | |a Sargos, Paul |4 oth | |
| 700 | 1 | |a Latorzeff, Igor |4 oth | |
| 700 | 1 | |a Lagrange, Jean-Léon |4 oth | |
| 700 | 1 | |a Supiot, Stéphane |4 oth | |
| 700 | 1 | |a Belkacemi, Yazid |4 oth | |
| 700 | 1 | |a Peiffert, Didier |4 oth | |
| 700 | 1 | |a Allouache, Nedla |4 oth | |
| 700 | 1 | |a Dubray, Bernard M |4 oth | |
| 700 | 1 | |a Servagi-Vernat, Stéphanie |4 oth | |
| 700 | 1 | |a Suchaud, Jean-Philippe |4 oth | |
| 700 | 1 | |a Crehange, Gilles |4 oth | |
| 700 | 1 | |a Guerif, Stéphane |4 oth | |
| 700 | 1 | |a Brihoum, Meryem |4 oth | |
| 700 | 1 | |a Barbier, Nicolas |4 oth | |
| 700 | 1 | |a Graff-Cailleaud, Pierre |4 oth | |
| 700 | 1 | |a Ruffion, Alain |4 oth | |
| 700 | 1 | |a Dussart, Sophie |4 oth | |
| 700 | 1 | |a Ferlay, Céline |4 oth | |
| 700 | 1 | |a Chabaud, Sylvie |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n The Lancet Publ. Group |a Citovsky, Vitaly ELSEVIER |t My |d 2019 |g London |w (DE-627)ELV003173852 |
| 773 | 1 | 8 | |g volume:20 |g year:2019 |g number:12 |g pages:1740-1749 |g extent:10 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/S1470-2045(19)30486-3 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a FID-BIODIV | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 35.70 |j Biochemie: Allgemeines |q VZ |
| 936 | b | k | |a 42.12 |j Biophysik |q VZ |
| 951 | |a AR | ||
| 952 | |d 20 |j 2019 |e 12 |h 1740-1749 |g 10 | ||
| author_variant |
c c cc |
|---|---|
| matchkey_str |
carriechristianmagnnicolasburbanprovostp:2019----:hrtradoedpiainhrpcmiewtrdohrpaslaeramnatraiapottcoyopottcnegtgf |
| hierarchy_sort_str |
2019 |
| bklnumber |
35.70 42.12 |
| publishDate |
2019 |
| allfields |
10.1016/S1470-2045(19)30486-3 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001094.pica (DE-627)ELV048678724 (ELSEVIER)S1470-2045(19)30486-3 DE-627 ger DE-627 rakwb eng 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl Carrie, Christian verfasserin aut Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial 2019 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Radiotherapy is the standard salvage treatment after radical prostatectomy. To date, the role of androgen deprivation therapy has not been formally shown. In this follow-up study, we aimed to update the results of the GETUG-AFU 16 trial, which assessed the efficacy of radiotherapy plus androgen suppression versus radiotherapy alone. Magné, Nicolas oth Burban-Provost, Patricia oth Sargos, Paul oth Latorzeff, Igor oth Lagrange, Jean-Léon oth Supiot, Stéphane oth Belkacemi, Yazid oth Peiffert, Didier oth Allouache, Nedla oth Dubray, Bernard M oth Servagi-Vernat, Stéphanie oth Suchaud, Jean-Philippe oth Crehange, Gilles oth Guerif, Stéphane oth Brihoum, Meryem oth Barbier, Nicolas oth Graff-Cailleaud, Pierre oth Ruffion, Alain oth Dussart, Sophie oth Ferlay, Céline oth Chabaud, Sylvie oth Enthalten in The Lancet Publ. Group Citovsky, Vitaly ELSEVIER My 2019 London (DE-627)ELV003173852 volume:20 year:2019 number:12 pages:1740-1749 extent:10 https://doi.org/10.1016/S1470-2045(19)30486-3 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ AR 20 2019 12 1740-1749 10 |
| spelling |
10.1016/S1470-2045(19)30486-3 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001094.pica (DE-627)ELV048678724 (ELSEVIER)S1470-2045(19)30486-3 DE-627 ger DE-627 rakwb eng 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl Carrie, Christian verfasserin aut Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial 2019 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Radiotherapy is the standard salvage treatment after radical prostatectomy. To date, the role of androgen deprivation therapy has not been formally shown. In this follow-up study, we aimed to update the results of the GETUG-AFU 16 trial, which assessed the efficacy of radiotherapy plus androgen suppression versus radiotherapy alone. Magné, Nicolas oth Burban-Provost, Patricia oth Sargos, Paul oth Latorzeff, Igor oth Lagrange, Jean-Léon oth Supiot, Stéphane oth Belkacemi, Yazid oth Peiffert, Didier oth Allouache, Nedla oth Dubray, Bernard M oth Servagi-Vernat, Stéphanie oth Suchaud, Jean-Philippe oth Crehange, Gilles oth Guerif, Stéphane oth Brihoum, Meryem oth Barbier, Nicolas oth Graff-Cailleaud, Pierre oth Ruffion, Alain oth Dussart, Sophie oth Ferlay, Céline oth Chabaud, Sylvie oth Enthalten in The Lancet Publ. Group Citovsky, Vitaly ELSEVIER My 2019 London (DE-627)ELV003173852 volume:20 year:2019 number:12 pages:1740-1749 extent:10 https://doi.org/10.1016/S1470-2045(19)30486-3 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ AR 20 2019 12 1740-1749 10 |
| allfields_unstemmed |
10.1016/S1470-2045(19)30486-3 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001094.pica (DE-627)ELV048678724 (ELSEVIER)S1470-2045(19)30486-3 DE-627 ger DE-627 rakwb eng 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl Carrie, Christian verfasserin aut Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial 2019 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Radiotherapy is the standard salvage treatment after radical prostatectomy. To date, the role of androgen deprivation therapy has not been formally shown. In this follow-up study, we aimed to update the results of the GETUG-AFU 16 trial, which assessed the efficacy of radiotherapy plus androgen suppression versus radiotherapy alone. Magné, Nicolas oth Burban-Provost, Patricia oth Sargos, Paul oth Latorzeff, Igor oth Lagrange, Jean-Léon oth Supiot, Stéphane oth Belkacemi, Yazid oth Peiffert, Didier oth Allouache, Nedla oth Dubray, Bernard M oth Servagi-Vernat, Stéphanie oth Suchaud, Jean-Philippe oth Crehange, Gilles oth Guerif, Stéphane oth Brihoum, Meryem oth Barbier, Nicolas oth Graff-Cailleaud, Pierre oth Ruffion, Alain oth Dussart, Sophie oth Ferlay, Céline oth Chabaud, Sylvie oth Enthalten in The Lancet Publ. Group Citovsky, Vitaly ELSEVIER My 2019 London (DE-627)ELV003173852 volume:20 year:2019 number:12 pages:1740-1749 extent:10 https://doi.org/10.1016/S1470-2045(19)30486-3 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ AR 20 2019 12 1740-1749 10 |
| allfieldsGer |
10.1016/S1470-2045(19)30486-3 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001094.pica (DE-627)ELV048678724 (ELSEVIER)S1470-2045(19)30486-3 DE-627 ger DE-627 rakwb eng 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl Carrie, Christian verfasserin aut Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial 2019 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Radiotherapy is the standard salvage treatment after radical prostatectomy. To date, the role of androgen deprivation therapy has not been formally shown. In this follow-up study, we aimed to update the results of the GETUG-AFU 16 trial, which assessed the efficacy of radiotherapy plus androgen suppression versus radiotherapy alone. Magné, Nicolas oth Burban-Provost, Patricia oth Sargos, Paul oth Latorzeff, Igor oth Lagrange, Jean-Léon oth Supiot, Stéphane oth Belkacemi, Yazid oth Peiffert, Didier oth Allouache, Nedla oth Dubray, Bernard M oth Servagi-Vernat, Stéphanie oth Suchaud, Jean-Philippe oth Crehange, Gilles oth Guerif, Stéphane oth Brihoum, Meryem oth Barbier, Nicolas oth Graff-Cailleaud, Pierre oth Ruffion, Alain oth Dussart, Sophie oth Ferlay, Céline oth Chabaud, Sylvie oth Enthalten in The Lancet Publ. Group Citovsky, Vitaly ELSEVIER My 2019 London (DE-627)ELV003173852 volume:20 year:2019 number:12 pages:1740-1749 extent:10 https://doi.org/10.1016/S1470-2045(19)30486-3 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ AR 20 2019 12 1740-1749 10 |
| allfieldsSound |
10.1016/S1470-2045(19)30486-3 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001094.pica (DE-627)ELV048678724 (ELSEVIER)S1470-2045(19)30486-3 DE-627 ger DE-627 rakwb eng 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl Carrie, Christian verfasserin aut Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial 2019 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Radiotherapy is the standard salvage treatment after radical prostatectomy. To date, the role of androgen deprivation therapy has not been formally shown. In this follow-up study, we aimed to update the results of the GETUG-AFU 16 trial, which assessed the efficacy of radiotherapy plus androgen suppression versus radiotherapy alone. Magné, Nicolas oth Burban-Provost, Patricia oth Sargos, Paul oth Latorzeff, Igor oth Lagrange, Jean-Léon oth Supiot, Stéphane oth Belkacemi, Yazid oth Peiffert, Didier oth Allouache, Nedla oth Dubray, Bernard M oth Servagi-Vernat, Stéphanie oth Suchaud, Jean-Philippe oth Crehange, Gilles oth Guerif, Stéphane oth Brihoum, Meryem oth Barbier, Nicolas oth Graff-Cailleaud, Pierre oth Ruffion, Alain oth Dussart, Sophie oth Ferlay, Céline oth Chabaud, Sylvie oth Enthalten in The Lancet Publ. Group Citovsky, Vitaly ELSEVIER My 2019 London (DE-627)ELV003173852 volume:20 year:2019 number:12 pages:1740-1749 extent:10 https://doi.org/10.1016/S1470-2045(19)30486-3 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ AR 20 2019 12 1740-1749 10 |
| language |
English |
| source |
Enthalten in My London volume:20 year:2019 number:12 pages:1740-1749 extent:10 |
| sourceStr |
Enthalten in My London volume:20 year:2019 number:12 pages:1740-1749 extent:10 |
| format_phy_str_mv |
Article |
| bklname |
Biochemie: Allgemeines Biophysik |
| institution |
findex.gbv.de |
| dewey-raw |
570 |
| isfreeaccess_bool |
false |
| container_title |
My |
| authorswithroles_txt_mv |
Carrie, Christian @@aut@@ Magné, Nicolas @@oth@@ Burban-Provost, Patricia @@oth@@ Sargos, Paul @@oth@@ Latorzeff, Igor @@oth@@ Lagrange, Jean-Léon @@oth@@ Supiot, Stéphane @@oth@@ Belkacemi, Yazid @@oth@@ Peiffert, Didier @@oth@@ Allouache, Nedla @@oth@@ Dubray, Bernard M @@oth@@ Servagi-Vernat, Stéphanie @@oth@@ Suchaud, Jean-Philippe @@oth@@ Crehange, Gilles @@oth@@ Guerif, Stéphane @@oth@@ Brihoum, Meryem @@oth@@ Barbier, Nicolas @@oth@@ Graff-Cailleaud, Pierre @@oth@@ Ruffion, Alain @@oth@@ Dussart, Sophie @@oth@@ Ferlay, Céline @@oth@@ Chabaud, Sylvie @@oth@@ |
| publishDateDaySort_date |
2019-01-01T00:00:00Z |
| hierarchy_top_id |
ELV003173852 |
| dewey-sort |
3570 |
| id |
ELV048678724 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV048678724</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624145646.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">200108s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S1470-2045(19)30486-3</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001094.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV048678724</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1470-2045(19)30486-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.70</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Carrie, Christian</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Radiotherapy is the standard salvage treatment after radical prostatectomy. To date, the role of androgen deprivation therapy has not been formally shown. In this follow-up study, we aimed to update the results of the GETUG-AFU 16 trial, which assessed the efficacy of radiotherapy plus androgen suppression versus radiotherapy alone.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Magné, Nicolas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Burban-Provost, Patricia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sargos, Paul</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Latorzeff, Igor</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lagrange, Jean-Léon</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Supiot, Stéphane</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Belkacemi, Yazid</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Peiffert, Didier</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Allouache, Nedla</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dubray, Bernard M</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Servagi-Vernat, Stéphanie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Suchaud, Jean-Philippe</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Crehange, Gilles</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Guerif, Stéphane</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brihoum, Meryem</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Barbier, Nicolas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Graff-Cailleaud, Pierre</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ruffion, Alain</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dussart, Sophie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ferlay, Céline</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chabaud, Sylvie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">The Lancet Publ. Group</subfield><subfield code="a">Citovsky, Vitaly ELSEVIER</subfield><subfield code="t">My</subfield><subfield code="d">2019</subfield><subfield code="g">London</subfield><subfield code="w">(DE-627)ELV003173852</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:20</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:12</subfield><subfield code="g">pages:1740-1749</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S1470-2045(19)30486-3</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.70</subfield><subfield code="j">Biochemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.12</subfield><subfield code="j">Biophysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">20</subfield><subfield code="j">2019</subfield><subfield code="e">12</subfield><subfield code="h">1740-1749</subfield><subfield code="g">10</subfield></datafield></record></collection>
|
| author |
Carrie, Christian |
| spellingShingle |
Carrie, Christian ddc 570 fid BIODIV bkl 35.70 bkl 42.12 Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial |
| authorStr |
Carrie, Christian |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV003173852 |
| format |
electronic Article |
| dewey-ones |
570 - Life sciences; biology |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial |
| topic |
ddc 570 fid BIODIV bkl 35.70 bkl 42.12 |
| topic_unstemmed |
ddc 570 fid BIODIV bkl 35.70 bkl 42.12 |
| topic_browse |
ddc 570 fid BIODIV bkl 35.70 bkl 42.12 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
n m nm p b p pbp p s ps i l il j l l jll s s ss y b yb d p dp n a na b m d bm bmd s s v ssv j p s jps g c gc s g sg m b mb n b nb p g c pgc a r ar s d sd c f cf s c sc |
| hierarchy_parent_title |
My |
| hierarchy_parent_id |
ELV003173852 |
| dewey-tens |
570 - Life sciences; biology |
| hierarchy_top_title |
My |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV003173852 |
| title |
Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial |
| ctrlnum |
(DE-627)ELV048678724 (ELSEVIER)S1470-2045(19)30486-3 |
| title_full |
Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial |
| author_sort |
Carrie, Christian |
| journal |
My |
| journalStr |
My |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
500 - Science |
| recordtype |
marc |
| publishDateSort |
2019 |
| contenttype_str_mv |
zzz |
| container_start_page |
1740 |
| author_browse |
Carrie, Christian |
| container_volume |
20 |
| physical |
10 |
| class |
570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Carrie, Christian |
| doi_str_mv |
10.1016/S1470-2045(19)30486-3 |
| dewey-full |
570 |
| title_sort |
short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (getug-afu 16): a 112-month follow-up of a phase 3, randomised trial |
| title_auth |
Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial |
| abstract |
Radiotherapy is the standard salvage treatment after radical prostatectomy. To date, the role of androgen deprivation therapy has not been formally shown. In this follow-up study, we aimed to update the results of the GETUG-AFU 16 trial, which assessed the efficacy of radiotherapy plus androgen suppression versus radiotherapy alone. |
| abstractGer |
Radiotherapy is the standard salvage treatment after radical prostatectomy. To date, the role of androgen deprivation therapy has not been formally shown. In this follow-up study, we aimed to update the results of the GETUG-AFU 16 trial, which assessed the efficacy of radiotherapy plus androgen suppression versus radiotherapy alone. |
| abstract_unstemmed |
Radiotherapy is the standard salvage treatment after radical prostatectomy. To date, the role of androgen deprivation therapy has not been formally shown. In this follow-up study, we aimed to update the results of the GETUG-AFU 16 trial, which assessed the efficacy of radiotherapy plus androgen suppression versus radiotherapy alone. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA |
| container_issue |
12 |
| title_short |
Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial |
| url |
https://doi.org/10.1016/S1470-2045(19)30486-3 |
| remote_bool |
true |
| author2 |
Magné, Nicolas Burban-Provost, Patricia Sargos, Paul Latorzeff, Igor Lagrange, Jean-Léon Supiot, Stéphane Belkacemi, Yazid Peiffert, Didier Allouache, Nedla Dubray, Bernard M Servagi-Vernat, Stéphanie Suchaud, Jean-Philippe Crehange, Gilles Guerif, Stéphane Brihoum, Meryem Barbier, Nicolas Graff-Cailleaud, Pierre Ruffion, Alain Dussart, Sophie Ferlay, Céline Chabaud, Sylvie |
| author2Str |
Magné, Nicolas Burban-Provost, Patricia Sargos, Paul Latorzeff, Igor Lagrange, Jean-Léon Supiot, Stéphane Belkacemi, Yazid Peiffert, Didier Allouache, Nedla Dubray, Bernard M Servagi-Vernat, Stéphanie Suchaud, Jean-Philippe Crehange, Gilles Guerif, Stéphane Brihoum, Meryem Barbier, Nicolas Graff-Cailleaud, Pierre Ruffion, Alain Dussart, Sophie Ferlay, Céline Chabaud, Sylvie |
| ppnlink |
ELV003173852 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/S1470-2045(19)30486-3 |
| up_date |
2024-07-06T19:30:08.272Z |
| _version_ |
1803859219734069248 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV048678724</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624145646.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">200108s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S1470-2045(19)30486-3</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001094.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV048678724</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1470-2045(19)30486-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.70</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Carrie, Christian</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Radiotherapy is the standard salvage treatment after radical prostatectomy. To date, the role of androgen deprivation therapy has not been formally shown. In this follow-up study, we aimed to update the results of the GETUG-AFU 16 trial, which assessed the efficacy of radiotherapy plus androgen suppression versus radiotherapy alone.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Magné, Nicolas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Burban-Provost, Patricia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sargos, Paul</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Latorzeff, Igor</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lagrange, Jean-Léon</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Supiot, Stéphane</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Belkacemi, Yazid</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Peiffert, Didier</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Allouache, Nedla</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dubray, Bernard M</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Servagi-Vernat, Stéphanie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Suchaud, Jean-Philippe</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Crehange, Gilles</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Guerif, Stéphane</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brihoum, Meryem</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Barbier, Nicolas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Graff-Cailleaud, Pierre</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ruffion, Alain</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dussart, Sophie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ferlay, Céline</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chabaud, Sylvie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">The Lancet Publ. Group</subfield><subfield code="a">Citovsky, Vitaly ELSEVIER</subfield><subfield code="t">My</subfield><subfield code="d">2019</subfield><subfield code="g">London</subfield><subfield code="w">(DE-627)ELV003173852</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:20</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:12</subfield><subfield code="g">pages:1740-1749</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S1470-2045(19)30486-3</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.70</subfield><subfield code="j">Biochemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.12</subfield><subfield code="j">Biophysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">20</subfield><subfield code="j">2019</subfield><subfield code="e">12</subfield><subfield code="h">1740-1749</subfield><subfield code="g">10</subfield></datafield></record></collection>
|
| score |
7.4021854 |